Is Cinnamon Good for Your Kidneys and Liver?

Cinnamon contains compounds that show genuine protective effects on both the kidneys and liver in laboratory and animal research, but the same spice also carries a well-documented risk of liver damage depending on the type, the dose, and your individual metabolism. The answer hinges on a distinction most people never think about: whether the cinnamon in your cabinet is cassia or Ceylon, and whether you are sprinkling it on oatmeal or swallowing it in supplement capsules. The science is more nuanced than the supplement industry would like, and the risks are more specific than the fear-based headlines suggest.

The Type of Cinnamon Changes Everything

Most cinnamon sold worldwide is cassia cinnamon, which comes from a different botanical species than Ceylon cinnamon (sometimes marketed as “true” cinnamon). The practical difference that matters for your organs is coumarin, a naturally occurring compound found at high levels in cassia bark. Testing of retail cinnamon powders has found that cassia products contain substantial coumarin, with enormous variation from sample to sample, ranging from barely detectable amounts to very high concentrations even within the same package of sticks.¹ Ceylon cinnamon, by contrast, contains almost negligible coumarin, typically less than 0.01 mg per gram of dry weight.²

This distinction matters because coumarin is the compound responsible for the liver concerns, while the beneficial compounds, especially cinnamaldehyde, are present in both types. So when someone asks whether cinnamon helps or harms the liver, they are really asking about two different chemical stories happening simultaneously.

Evidence That Cinnamon Protects the Liver

The most interesting human evidence comes from a clinical trial in people with non-alcoholic fatty liver disease. Participants who took 1,500 mg of cinnamon daily showed significant drops in liver enzymes (ALT, AST, and GGT), fasting blood sugar, cholesterol, triglycerides, insulin resistance, and a marker of inflammation called high-sensitivity C-reactive protein.³ Those are meaningful markers. Lower liver enzymes suggest less ongoing damage to liver cells, and reduced insulin resistance addresses one of the root drivers of fatty liver disease.

Animal research reinforces these findings. In rats fed a high-fat diet to induce liver damage, cinnamaldehyde treatment significantly lowered liver enzymes and triglyceride accumulation in the liver, and reduced oxidative stress. Tissue examination confirmed less fat buildup in liver cells.⁴ The mechanism appears to involve cinnamaldehyde activating a protective signaling pathway called Nrf2, which ramps up the body’s antioxidant defenses.⁵

The catch is that the human evidence is still thin. One clinical trial, however encouraging, is not enough to make a treatment recommendation. And the doses used in research, often 1,000 to 6,000 mg per day in capsule form, are far above what you would get from culinary use.

When Cinnamon Damages the Liver

The liver-damage side of the story is about coumarin, and it is well established enough that European regulators have set a tolerable daily intake. The European Food Safety Authority placed the limit at 0.1 mg of coumarin per kilogram of body weight per day, based on chronic toxicity studies.⁶ A separate analysis using a different statistical approach arrived at a slightly lower figure of 0.07 mg per kilogram per day.⁷ For a 70 kg adult, that works out to roughly 5 to 7 mg of coumarin per day as the upper safe limit. Given the coumarin content of cassia cinnamon (around 2.2 mg per gram on average), even a single teaspoon of cassia powder could approach or exceed that threshold.

The damage does not happen to everyone. Coumarin-induced liver injury appears to be restricted to a small subset of people, likely those whose bodies metabolize coumarin through alternative pathways that produce toxic byproducts. Specific liver enzymes in the cytochrome P450 family, particularly CYP1A and CYP2E1, can convert coumarin into a reactive compound called coumarin 3,4-epoxide, which is what actually injures liver cells.⁸ Most people detoxify coumarin through a harmless pathway instead. But you cannot easily know which group you fall into.⁹

Case reports illustrate how serious this can get. One documented case involved a 40-year-old man who developed jaundice after about four months of taking over-the-counter herbal products containing cinnamon. A review of 13 reported cases of cinnamon-related liver injury found severe abnormalities in clotting function and bilirubin levels, and the authors noted that liver failure from cinnamon is a real possibility.¹⁰ Other case reports have linked cinnamon supplements specifically to acute hepatitis.¹¹

The paradox here is genuine: cinnamaldehyde can protect the liver while coumarin, present in the same bark, can destroy it. This is why the type of cinnamon matters so much. Ceylon cinnamon gives you the cinnamaldehyde with barely any coumarin. Cassia gives you both.

What the Kidney Research Shows

Kidney research on cinnamon is almost entirely confined to animal and cell studies, but the findings are consistently encouraging. A review focused on cinnamon and chronic kidney disease concluded that cinnamon’s bioactive compounds, including cinnamaldehyde and cinnamic acid, can reduce oxidative stress, inflammation, high blood sugar, and abnormal blood lipids, all of which are common problems in kidney disease patients.¹²

Several lines of animal evidence stand out. In rats with chemotherapy-induced kidney damage from cisplatin (a widely used cancer drug known for its kidney toxicity), both cinnamic acid and cinnamaldehyde given before cisplatin treatment protected kidney function. They restored normal kidney markers and reduced the tissue damage visible under a microscope, with cinnamaldehyde outperforming cinnamic acid.¹³ In a study of radiation-induced kidney damage, cinnamaldehyde acted as a potent free-radical scavenger, reducing inflammation and tissue injury.¹⁴ And in a model of sepsis-triggered acute kidney injury, cinnamaldehyde protected kidney cells from a specific type of cell death called ferroptosis by activating the same Nrf2 antioxidant pathway seen in liver studies.¹⁵

The kidney-protective theme here is consistent: cinnamaldehyde appears to defend kidney tissue against oxidative damage from multiple different sources. But “appears to” is doing a lot of work in that sentence. These are animal studies using isolated compounds, often delivered at doses or by methods that do not resemble eating cinnamon. No large human clinical trial has tested whether cinnamon supplements protect kidneys in practice.

Diabetic Kidney Disease Gets the Most Attention

Diabetes is the leading cause of kidney disease worldwide, so cinnamon’s well-known blood-sugar-lowering effects make it an obvious candidate for protecting kidneys indirectly. The animal research on diabetic kidney damage specifically is promising. In diabetic rats, cinnamon extract and a fraction enriched with a specific compound called procyanidin-B2 reduced the formation of advanced glycation end-products (harmful molecules that accumulate when blood sugar stays high), which in turn improved kidney function as measured by reduced albumin and creatinine in urine.¹⁶

More recently, cinnamic acid (another compound from cinnamon) was tested in a rat model of type 2 diabetes and was found to significantly improve kidney function. Treated animals showed lower blood urea nitrogen, creatinine, and urinary albumin, along with reduced markers of both glomerular and tubular injury in the kidneys.¹⁷ The proposed mechanism is particularly interesting: cinnamic acid appeared to act as an inhibitor of a protein involved in glucose reabsorption in the kidneys, a target already used by an established class of diabetes drugs.

These findings suggest that cinnamon compounds could help kidneys in diabetic patients through multiple routes: lowering blood sugar, reducing the toxic byproducts of chronic high glucose, and potentially even mimicking the kidney-protective effects of existing medications. But the gap between rat kidneys and human kidneys remains large, and translation from one to the other frequently fails.

Cinnamon and Kidney Stones

If you have heard that spices raise kidney stone risk, you might be thinking of turmeric, not cinnamon. Oxalate is a compound that can combine with calcium in urine to form the most common type of kidney stone. A study that measured urinary oxalate after people consumed supplemental doses of both spices found that turmeric significantly increased urinary oxalate excretion while cinnamon did not. The reason was straightforward: only about 6% of the oxalate in cinnamon was in a water-soluble form that the body can absorb, compared to 91% for turmeric.¹⁸ So if kidney stones are your primary concern, cinnamon looks relatively benign compared to some other popular spices.

Drug Interactions You Should Know About

One underappreciated risk of cinnamon, especially in supplement form, is its potential to interact with medications. Cinnamaldehyde and related compounds in cinnamon inhibit several of the liver enzymes responsible for metabolizing drugs. Research has shown that cinnamaldehyde causes time-dependent inhibition of an enzyme called CYP2A6, which metabolizes nicotine and the breast cancer drug letrozole. Modeling predicted that heavy cinnamon exposure (equivalent to roughly 275 mg of cinnamaldehyde) could lead to roughly four- to five-fold increases in drug exposure for substrates of that enzyme.¹⁹

Other studies have found that cinnamaldehyde and cinnamon oil also inhibit CYP2C9 and CYP1A2, enzymes that process a wide range of common medications. The researchers cautioned that while controlled food-level intake is likely fine, overconsumption of cinnamon supplements could trigger significant herb-drug interactions, particularly in people with chronic health conditions who are already on multiple medications.²⁰ A separate study identified o-methoxycinnamaldehyde from cinnamon bark as a competitive inhibitor of CYP1A2 and a mixed-type inhibitor of CYP2E1.²¹

If you take medications processed by any of these enzymes and you are also taking cinnamon supplements, the drug could build up in your system to higher-than-intended levels. This is not a concern with a dash of cinnamon in your coffee, but it becomes relevant with the concentrated doses found in supplement capsules.

Lead Contamination in Cinnamon Products

A risk that has nothing to do with cinnamon’s own chemistry surfaced in 2023, when children in the United States were found to have elevated blood lead levels after consuming apple-cinnamon fruit puree manufactured in Ecuador. An investigation of 61 cinnamon samples from Ecuadorian markets found that ground cinnamon had nearly twice the lead content of stick cinnamon, and several ground samples exceeded the maximum lead levels set by both Ecuadorian and European Union regulations.²² Lead contamination can occur during growing, drying, grinding, and packaging, and it tends to be worse in ground spices because contaminated surface material gets mixed throughout the product.

Lead is toxic to both the kidneys and liver, which makes this a particularly ironic risk for anyone taking cinnamon specifically for organ protection. If you are choosing cinnamon supplements or large quantities of ground cinnamon, sourcing matters. Products tested by third-party labs for heavy metals offer some protection against this risk.

What You Are Actually Buying

One of the more frustrating aspects of this topic is that you often cannot tell what kind of cinnamon you are getting. An analysis of cinnamon labeling across 40 international markets found widespread problems. Ceylon cinnamon’s main selling point, its ultra-low coumarin content, was rarely highlighted on labels. Meanwhile, cassia cinnamon, with its much higher coumarin levels, dominated store shelves, often with labels that made no attempt to distinguish it from Ceylon.² If you live in North America and grab a jar labeled “cinnamon” from a grocery shelf, it is almost certainly cassia.

For someone using cinnamon as a cooking spice in normal amounts, the labeling issue is mostly academic. The coumarin exposure from a pinch in your oatmeal or a stick in your mulled cider is unlikely to be a problem for most people. The labeling gap becomes genuinely important if you are taking cinnamon therapeutically at higher doses, because the difference between 0.01 mg and 2.2 mg of coumarin per gram means the cassia product delivers roughly 200 times more of the compound linked to liver damage. If you are supplementing, specifically seeking out Ceylon cinnamon is the single most practical step you can take to reduce your risk.

Culinary Amounts Versus Supplement Doses

Clinical trials looking for benefits from cinnamon have used doses ranging from 500 mg to 6,000 mg per day in powder or capsule form, typically for periods of six weeks to four months. That is equivalent to roughly a quarter-teaspoon on the low end to nearly two teaspoons on the high end, consumed daily without fail. Most people’s actual dietary exposure is far below this, usually a fraction of a gram per day on days they eat anything with cinnamon at all.

The protective effects seen in the fatty liver trial used 1,500 mg per day.³ At that dose of cassia cinnamon, you would be ingesting roughly 3.3 mg of coumarin daily, which is within range of the tolerable daily intake for an average-sized adult but could exceed it for smaller individuals. This is the tension at the heart of the question: the dose needed for potential benefits overlaps with the dose that starts to raise coumarin concerns, at least with cassia. Ceylon cinnamon largely resolves this problem, but most of the clinical trials were conducted with cassia, so we cannot assume the results transfer perfectly.

For your kidneys specifically, the culinary-versus-supplement distinction is less fraught. The kidney stone data is reassuring at food-level doses, and the protective effects seen in animal studies involve cinnamaldehyde, which you get from any type of cinnamon. The risk at typical dietary levels is negligible. The theoretical kidney benefits, though, are still extrapolations from animal models. No one has shown in a human trial that adding cinnamon to your diet protects kidney function over time.

Cinnamon and Liver Enzyme Monitors

If you have an existing liver condition or are on medications that affect the liver, adding cinnamon supplements introduces a variable that can confuse both you and your doctor. Elevated liver enzymes on a blood test could reflect the underlying condition worsening, a medication side effect, or a reaction to cinnamon’s coumarin content. In the clinical trial of fatty liver patients, cinnamon lowered liver enzymes. In case reports of cinnamon toxicity, liver enzymes spiked dramatically. The direction depends entirely on individual susceptibility, the type and dose of cinnamon, and whether the liver is already under strain from other causes.

If you are supplementing with cinnamon and notice worsening liver function on blood work, stopping the cinnamon is a reasonable first step. The liver injury reported in case studies has generally been reversible upon discontinuation, though severe cases required hospitalization.¹⁰ Anyone taking cinnamon at supplement-level doses for more than a few weeks should be getting periodic liver function tests, especially if they are using cassia cinnamon.